Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

NCT01844973 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: M518101
DRUG: Vehicle

Sponsor

Maruho North America Inc.